West Pharmaceutical Services reported $238.7M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Align Technology ALGN:US $ 272.03M 64.35M
Antares Pharma ATRS:US $ 7.71M 1.42M
Avanos Medical Inc AVNS:US $ 19.1M 1.4M
Baxter International BAX:US $ 698M 45M
Becton, Dickinson and BDX:US $ 1094M 316M
Catalent CTLT:US $ 326.3M 57.5M
Charles River Laboratories CRL:US $ 209.66M 23.6M
Cooper Companies COO:US $ 138.8M 87.9M
Dentsply International XRAY:US 250M 5M
Haemonetics HAE:US $ 50.56M 23.84M
Icu Medical ICUI:US $ 60.49M 8.69M
Insulet PODD:US $ 41.5M 12.4M
Integra Lifesciences IART:US $ 84.86M 2.26M
IQVIA Holdings Inc IQV:US $ 648M 26M
Johnson & Johnson JNJ:US $ 8103M 786M
Medtronic MDT:US $ 1567M 1114M
Meridian Bioscience VIVO:US $ 20.16M 18.77M
Merit Medical Systems MMSI:US $ 39.03M 3.44M
Neogen NEOG:US $ 27.43M 1.24M
Quidel QDEL:US $ 38.82M 198.8M
Repligen RGEN:US $ 60.44M 10.97M
Sientra SIEN:US $ -8.43M 0.01M
Staar Surgical STAA:US $ 11.55M 3.2M
West Pharmaceutical Services WST:US $ 238.7M 33M